Journal of Substance Abuse Treatment
Volume 37, Issue 3 , Pages 292-297 , October 2009

Drug abstinence and cognitive control in methamphetamine-dependent individuals

  • Ruth Salo, Ph.D

      Affiliations

    • UC Davis Imaging Research Center, Sacramento, CA
    • Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA
    • Corresponding Author InformationCorresponding author. UC Davis Imaging Research Center 4701 X Street, Sacramento, CA. Tel.: +1 916 734 7909; fax: +1 916 734 8520.
    • ,
  • Thomas E. Nordahl, MD, Ph.D

      Affiliations

    • UC Davis Imaging Research Center, Sacramento, CA
    • Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA
    • ,
  • Gantt P. Galloway, PharmD.

      Affiliations

    • St. Luke's Hospital, San Francisco, CA
    • ,
  • Charles D. Moore, M.D.

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA
    • Kaiser Chemical Dependence Recovery Program, Sacramento, CA
    • ,
  • Christy Waters

      Affiliations

    • St. Luke's Hospital, San Francisco, CA
    • ,
  • Martin H. Leamon, M.D.

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA

Received 10 October 2008 ,Revised 28 January 2009 ,Accepted 2 March 2009.

References 

  1. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD. Conflict monitoring and cognitive control. Psychological Review. 2001;108:624–652
  2. Boucart M, Mobarek N, Cuervo C, Danion JM. What is the nature of increased Stroop interference in schizophrenia?. Acta Psychologica. 1999;101:3–25
  3. Carter CS, Robertson LC, Nordahl TE. Abnormal processing of irrelevant information in chronic schizophrenia: Selective enhancement of Stroop facilitation. Psychiatry Research. 1992;41:137–146
  4. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, et al. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Research. 2002;114:65–79
  5. Community Epidemiology Work Group . Epidemiologic trends in drug abuse: Advance report: Prescription drug abuse, June 2004 (NIH Publication No. 04-5363A). Bethesda, MD: National Institute on Drug Abuse; 2004;[Available as a PDF at http://www.drugabuse.gov/PDF/CEWG/AdvReport604.pdf]
  6. First MB, Spitzer L, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders. New York, NY: Biometrics Research Department; 1995;
  7. Gibson DR, Leamon MH, Flynn N. Epidemiology and public health consequences of methamphetamine use in California's Central Valley. Journal of Psychoactive Drugs. 2002;34:313–319
  8. Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. The Journal of Neuropsychiatry and Clinical Neurosciences. 2003;15:215–220
  9. MacLeod CM. Half a century of research on the Stroop effect: An integrative review. Psychological Bulletin. 1991;109:163–203
  10. McKetin R, Mattick RP. Attention and memory in illicit amphetamine users. Drug and Alcohol Dependence. 1997;48:235–242
  11. McKetin R, Mattick RP. Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls. Drug and Alcohol Dependence. 1998;50:181–184
  12. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug and Alcohol Dependence. 2005;79:273–277
  13. National Drug Intelligence Center . National Drug Threat Assessment 2006 (Report No. 2006-Q0317-001). Johnstown, PA: National Drug Intelligence Center; 2006;[Available at http://www.usdoj.gov/ndic/pubs11/18862/index.htm]
  14. Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. The Journal of Neuropsychiatry and Clinical Neurosciences. 2003;15:317–325
  15. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, et al. Methamphetamine users in sustained abstinence: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry. 2005;62:444–452
  16. Ochsner KN, Kosslyn SM, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, et al. Deficits in visual cognition and attention following bilateral anterior cingulotomy. Neuropsychologia. 2001;39:219–230
  17. Office of Applied Studies . Primary methamphetamine/amphetamine treatment admissions: 1992–2002. The DASIS Report; 2004;[Available at http://www.oas.samhsa.gov/facts.cfm]
  18. Office of Applied Studies . Treatment Episode Data Set (TEDS) highlights - 2004: National admissions to substance abuse treatment services (DHHS Publication No. SMA 06-4140, Drug and Alcohol Services Information System Series S-31). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2006;[Available at http://www.oas.samhsa.gov/dasis.htm#teds4]
  19. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA. Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biological Psychiatry. 2003;53:65–74
  20. Paulus MP, Tapert SF, Schuckit MA. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Archives of General Psychiatry. 2005;62:761–768
  21. Quinton MS, Yamamoto BK. Causes and consequences of methamphetamine and MDMA toxicity. The AAPS Journal. 2006;8:E337–E347
  22. Ratcliff R. Methods for dealing with reaction time outliers. Psychological Bulletin. 1993;114:510–532
  23. Salo R, Henik A, Robertson LC. Interpreting Stroop interference: An analysis of differences between task versions. Neuropsychology. 2001;15:462–471
  24. Salo R, Leamon MH, Natsuaki Y, Moore C, Waters C, Nordahl TE. Findings of preserved implicit attention in methamphetamine dependent subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2008;32:217–223
  25. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, et al. Attentional control and brain metabolite levels in methamphetamine abusers. Biological Psychiatry. 2007;61:1272–1280
  26. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Research. 2002;111:65–74
  27. Simon SL, Dacey J, Glynn S, Rawson R, Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. Journal of Substance Abuse Treatment. 2004;27:59–66
  28. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions. 2000;9:222–231
  29. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008;33:827–836
  30. Swick D, Jovanovic J. Anterior cingulate cortex and the Stroop task: Neuropsychological evidence for topographic specificity. Neuropsychologia. 2002;40:1240–1253
  31. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci. 2001;21:9414–9418

PII: S0740-5472(09)00032-4

doi: 10.1016/j.jsat.2009.03.004

Journal of Substance Abuse Treatment
Volume 37, Issue 3 , Pages 292-297 , October 2009

Article Tools